Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
With digitally available health records, individuals can avail paper-less health services under Ayushman Bharat Digital Mission (ABDM)
Jan Aushadhi Diwas celebrations to generate awareness about the usages of generic medicines and benefits of Jan Aushadhi Pariyojana
Sonowal exhorted young researchers and scientist to work on evidence based scientific research
Receives regulatory approval for its molecule ‘Selumetinib’ in India
Natco launched pomalidomide under their brand NAT-POMALIDOMIDE in strengths of 1 mg, 2 mg, 3 mg and 4 mg capsules
Merck and Ridgeback will appeal the decision and request a re-examination of the CHMP’s opinion.
This sBLA submission is supported by clinical, pre-clinical, and manufacturing data demonstrating the safety, tolerability, and immunogenicity of the bivalent vaccine.
Subscribe To Our Newsletter & Stay Updated